Cookie Img
Home » Products » Pharmaceutical Formulations » Ibrutinib

Ibrutinib

Ibrutinib
Ibrutinib
Send Inquiry
Product Code : 3s-822
Brand Name : 3S Corporation
Price And Quantity
  • Minimum Order Quantity
  • 10
  • Unit of Measure
  • Pack/Packs
Product Specifications
  • Physical Form
  • Tablets
Product Description

Ibrutinib (Imbruvica) is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.


Ibrutinib was created by scientists at Celera Genomics as a tool compound for studying BTK function, then developed by Pharmacyclics up to Phase II, then partnered with Johnson & Johnson. Pharmacyclics was acquired by AbbVie in May 2015, and Abbvie projected global sales of US$1 billion in 2016 and $5 billion in 2020.[1]

Trade Information
  • FOB Port
  • Mumbai
  • Payment Terms
  • Cash in Advance (CID)
  • Supply Ability
  • 10,000 Per Day
  • Delivery Time
  • 20 Days
  • Sample Available
  • Yes
  • Sample Policy
  • Contact us for information regarding our sample policy
  • Packaging Details
  • As per Order
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
  • Certifications
  • WHO GMP

3S CORPORATION
X


"We mainly export our products to the foreign countries."
Back to top
3S CORPORATION All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Ltd.